| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Integration Officer | Chief Regulatory Officer
1 company
Lloyd-Smith Malcolm is a Chief Integration Officer at NBIX. Recent filings cover 0 purchases and 45 sales. Those positions are worth an estimated $4.4M at current prices.
Our model assigns Lloyd-Smith Malcolm a below-average insider score of 49/100, based on 8 past trades. Over a 12-month horizon, 12.5% of those trades were profitable, with an average 12-month return of -22.8%.
Lloyd-Smith Malcolm's largest disclosed position is in NBIX as Chief Integration Officer, worth about $4.4M. The recent filings there lean toward selling, a net 187,034 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 12, 2017 | NBIX Neurocrine Biosciences Inc | Chief Regulatory Officer | Sell | 13,065 | $50.42 | $658,773.93 | -50.1% | |
| Feb 7, 2017 | NBIX Neurocrine Biosciences Inc | Chief Regulatory Officer | Sell | 843 | $43.35 | $36,544.81 | -43.8% |